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The role of apoptosis in bispecific antibody-mediated T-cell cytotoxicity
BJ Kroesen, GJ Wellenberg, A Bakker, W Helfrich, TH The and L de Leij
Department of Clinical Immunology, University Hospital Groningen, Oostersingel 59, 9713 EZ Groningen, The Netherlands.
Summary In this report we describe the role of apoptosis in the process of tumour cell killing by bispecific
monoclonal antibody (BsMAb)-redirected cytolytic T cells. The BsMAb used, BIS-1, has dual specificity for
the CD3 complex on T cells and the pancarcinoma-associated 38 kDa transmembrane antigen EGP-2. BIS-1
allows activated T cells to specifically recognise and kill EGP-2-positive but not EGP-2-negative target cells.
An assay was developed to quantify apoptosis in cells by separation of 3H-thymidine-labelled low-molecular,
i.e. fragmented, from high-molecular, i.e. non-fragmented DNA. The presence of low molecular weight DNA
was measured both within the target cells and in the cell-free supernatant. After exposure to BIS-1-redirected,
-activated T cells, apoptosis was observed in EGP-2-positive target cells but not in EGP-2-negative target
cells. Also no DNA fragmentation proved to be induced in the activated effector cells during assay. The
degree of EGP-2-positive target DNA fragmentation depended on the concentration of BsMAb, the E/T ratio
and the incubation time. Using a low E/T ratio (1/1), DNA fragmentation in and 5'Cr release from target
cells showed similar characteristics and kinetics. At higher E/T ratio (20/1), the 5"Cr release from the target
cells increased to a greater extent than the percentage fragmented target cell DNA. Inhibitors of DNA
fragmentation added to the cytotoxicity assay inhibited not only DNA fragmentation, but also the release of
chromium-51 from the target cells, suggesting that apoptosis and cell lysis are closely related in BsMAb-
mediated cell killing.
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Activated cytotoxic T lymphocytes (CTLs) kill opposing
target cells upon MHC class I restricted recognition. Direct
bispecific monoclonal antibody (BsMAb)-mediated linking of
some cell-surface molecules present on the CTLs with cell-
surface molecules present on a target cell can direct the lethal
hit of the CTLs towards a prechosen target cell population
(Staerz et al., 1985; Garrido et al., 1990; Ferrini et al., 1992).
This BsMAb-redirected lysis is conducted irrespective of
MHC class I expression by the target cells and T-cell receptor
(TcR) specificity of the CTLs (Garrido et al., 1990).
Presumably the most potent T-cell surface structure that
can be used to redirect the CTL activity is the CD3/TcR
complex as present on all T lymphocytes (Garrido et al.,
1990; Ferrini et al., 1992).
CTLs may kill target cells by various mechanisms. The
exact pathways or possible interplay between these mechan-
isms is as yet not fully understood (Berke, 1991; Krahenbuhl
and Tschopp, 1991; Smyth et al., 1994; Smyth, 1992; Lowin
et al., 1994). CTLs contain granules in which a number of
lytic molecules have been characterised. These include
perforin or lymphotoxin, serine esterase or granzymes and
proteoglycans. Proteoglycans are not lytic by themselves but
are able to bind other lytic components and are thus thought
to play a role in the deposition of the lytic constituents at the
interface between the effector and target cell. Isolated
perforin has been shown to be cytotoxic as it inserts itself
in the cell membrane followed by polymerisation to form
tubular structures that allow uncontrolled passage of small
electrolytes and possibly larger macromolecules resulting in
cell death by disturbed cellular homeostasis (Duke et al.,
1989). Both the insertion in the cell membrane and the
polymerisation to transmembrane channels is dependent on
the presence of Ca2 . The CTL-associated serine esterases or
granzymes belong to a family of related serine proteases with
a variety of substrate specificities (Peters et al., 1991; Das et
al., 1994; Hayes et al., 1989; Wright et al., 1994; Krahenbuhl
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and Tschopp, 1991; Duke et al., 1989). Granzymes co-localise
with perforin in the lytic granules and have been shown to
induce target cell DNA fragmentation, possibly by activation
of intracellular endonucleases (Hayes et al., 1989; Smyth et
al., 1994; Hudig et al., 1993).
Although perforin is highly cytolytic by itself in the
presence of free extracellular Ca2", target cell lysis is
observed also under Ca2+-free conditions (Clark et al.,
1988; Rouvier et al., 1993). Furthermore, target cell lysis,
although only to a minor extent, can be established using
perforin-deficient CTLs (Kagl et al., 1994; Lowin et al.,
1994). These observations indicate the possibility that
multiple lytic mechanisms can be displayed by CTLs to kill
target cells. Indeed, it was recognised by Duke et al. (1983)
that, in addition to target cell membrane damage, the
induction of low molecular DNA, characteristic of apopto-
sis, was detectable during the process of cellular cytotoxicity.
One particular problem in assessing target cell apoptosis is
the fact that induction of DNA fragmentation may occur not
only in the target cell, but also in the effector cell population
(Lenardo, 1991; Ucker et al., 1992). To be able to identify the
nature of the assessed fragmented DNA, prelabelling of the
DNA of the cell population of interest can be done. In the
present report we have investigated the role of DNA
fragmentation in BsMAb-mediated anti-tumour activity by
detection and quantification of low molecular DNA using a
combination of 3H-thymidine-prelabelling and agarose gel
electrophoresis. BsMAb-mediated DNA fragmentation in-
duced by BIS-1-redirected activated CTLs was assessed in
EGP-2-positive and EGP-2-negative target cells and com-
pared with cell death as a result of cell membrane damage as
assessed in a classical 5'Cr-release assay. The BsMAb BIS-1
recognises both the CD3 complex on T lymphocytes and the
epithelial-related, pancarcinoma-associated 38 kDa trans-
membrane antigen EGP-2. EGP-2 has been described in a
number of clinical trials as target antigen for site-directed
immunotherapy of carcinomas using monoclonal- and
BsMAb-based immunotherapeutical modalities (Kroesen et
al., 1994; Moller and Reisfeld, 1991; Sindelar et al., 1986;
Mellstedt et al., 1989; 1991). Our results show that the
different mechanisms of BIS-1-mediated target cell lysis are
closely linked.Induction of apoptosis by BsMAb-targeted CTL
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Materials and methods
Target cell lines
GLC-1 (EGP-2 negative) and a clonal derivative thereof,
GLC-IM13 (EGP-2 positive), are human small-cell lung
cancer (SCLC)-derived cel lines (De Leij et al., 1985). The cell
lines were cultured according to routine procedures in culture
medium, i.e. RPMI-1640 (Gibco/BRL, Paisley, UK) supple-
mented with 14% heat-inactivated fetal calf serum (Gibco/
BRL), 2 mM glutamine (Gibco/BRL), 60 Mg ml-1 gentamicin
(Schering, Kenilworth, USA), 0.05 mM fl-mercaptoethanol
(Merck, Darmstadt, Germany) and 1 mm sodium pyruvate
(Gibco/BRL) at 37°C in a humidified atmosphere containing
5% carbon dioxide.
CTL isolation and activation
Peripheral blood mononuclear cells (PBMCs) were obtained
from heparinised peripheral blood. Isolation was done by
density centrifugation of diluted (1:1 in phosphate-buffered
saline; PBS) blood on lymphoprep (Nycomed, Oslo, Norway)
at 2400 r.p.m. for 20 min. The PBMC fraction was washed
twice by resuspension in RPMI-1640 and centrifugation at
1800 (first time) and 1200 (second time) r.p.m. for 10 min.
After isolation, PBMCs were collected in complete medium
consisting of RPMI-1640 supplemented with 2% heat-
inactivated human pooled serum, 2 mM gluatamine and 60
Mg ml- gentamicin. The CTL effector cells were prepared by
in vitro T-cell activation, which was done by incubating the
PBMCs for 3 days in complete medium supplemented with
5% (giving about 0.5 Mg ml-1 IgG ml-' end concentration)
culture supernatant of the mitogenic anti-CD3 MAb WT-32
(Tax et al., 1983), followed by washing and incubation for 2
additional days in complete medium supplemented with 100
IU ml-' interleukin 2 (IL-2) (EuroCetus, Amsterdam, The
Netherlands).
Bispecific antibody
The BsMAb BIS-1 was made and purified as described
(Kroesen et al., 1993). In short, the BIS-1-producing
quadroma was made by fusion of the hybridomas RIV-9
and MOC-31, producing anti-CD3 (IgG3) and anti-EGP-2
(IgGI) antibodies respectively. Purification of the hybrid
antibodies (IgG3/IgGl) from parental-type antibodies (IgG3
and IgGi), also produced by the quadroma, was done by
Protein A (Pharmacia, Uppsala, Sweden) column chromato-
graphy. Hollow fibre BIS-1 quadroma culture supernatant
was loaded onto the column at pH 7.3 and the different IgG
fractions were eluted successively by lowering the pH
stepwise. The purified BIS-1 was tested for its bispecific
characteristics both immunohistochemically and functionally
in cytotoxicity assays.
DNA fragmentation assay
A DNA fragmentation assay was developed based on a
modified procedure described by Duke et al. (1983) and
Curnow et al. (1993). Modifications were the use of [3H]-
thymidine instead of [5-'25I]iodo-2'-deoxyuridine for labelling
target cells and the introduction of an additional control
experiment from which the degree of spontaneous target cell
DNA fragmentation could be established. Before the assay,
5 x 106 target cells were labelled for 16 h at 37°C, 5% carbon
dioxide in 1 ml of fresh culture medium containing 10 MCi of
[3H]-thymidine (Amersham, Little Chalfont, UK). Unbound
label was removed by washing the cells four times with culture
medium. Aliquots of 50 Mtl of culture medium containing
5 x 104 target cells were pipetted into each well of a 96-well
round-bottom plate (Costar, Cambridge, MA, USA). Subse-
quently, 50 pl of culture medium containing various amounts
of BIS-1, IL-2 (400 IU ml-') and 100 pl of CTL effector cells
were added to each well to give the desired final BIS-1
concentration and effector to target ratio in a final volume of
200 Ml per well. The endonuclease inhibitors zinc chloride
(Merck) and 3,4-dichloroisocoumarin (Sigma Chemical Co, St
Louis, MO, USA) were added to the assay together with BIS-
1 at the indicated concentrations. All determinations were
done in quadruplicate. The microtitre plates were centrifuged
at 500 r.p.m. for 2 min to initiate cell-cell contact and
incubated at 37°C in 5% carbon dioxide for the indicated
times. After the incubation, the plates were centrifuged at
1000 r.p.m. for 5 min and the contents of the four wells of
each quadruplicate were pooled in an Eppendorf vial. Cells
were pelleted by centrifugation at 13 000 r.p.m. for 5 min
after which 100 Ml aliquots of the supernatants were mixed
with 1 ml of Hisafe scintillation fluid (LKB Pharmacia,
Uppsala, Sweden) and counted using a scintillation counter.
The rest of the supernatant was discarded and the cell pellets
were mixed and lysed in 60 Ml of lysis buffer containing 0.5%
sodium-N-lauroylsarkosine (Sigma), 0.5 mg ml-' RNAase
(Boehringer Mannheim, Germany), 1 mg ml-' proteinase K
(Pharmacia) in 50 mM Tris-HCl, pH 8.0. After incubation for
2 h at 50°C, 30 pl of the lysed pellet suspension was removed,
mixed with 1 ml ofHisafe scintillation fluid and counted using
a scintillation counter.
Quantification of DNA fragmentation
Visualisation and quantification of DNA fragmentation was
done after separation by agarose gel electrophoresis. An
aliquot of 7 Ml of gel electrophoresis loading buffer (0.04%
bromophenol blue, 0.06% xylene cyanol FF and 20% Ficoll
400) was added to 30 Ml of lysed cell pellet suspension and
mixed. This mixture was then loaded into dry wells of a 1.5%
LMP agarose gel (Gibco/BRL) containing 0.5 Mg ml-1
ethidium bromide. After sample loading, electrophoresis
was performed for 2-3 h at 100 V in TAE buffer (40 mM
Tris-acetate, 1 mM EDTA). DNA was visualised by UV
Figure 1 DNA fragmentation as a result of cytolytic activity of
activated CTLs against GLC-lM13 (lanes 2 and 3) and GLC-1
(lanes 4 and 5) target cells in the presence (lanes 2 and 4) or
absence (lanes 3 and 5) of the BsMAb BIS-1. BIS-1-targeted
activated CTLs induce DNA fragmentation exclusively in EGP-2-
positive GLC-IM13 target cells. CTLs incubated with BIS-1 do
not undergo DNA fragmentation (lane 1). DNA fragmentation
was assessed after 3h at an E/T ratio of 20.xkctmon of apoptosis by BsMAb-targetd CT
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translumination. Quantification of DNA fragmentation was
done by segmentation of the gel into individual lanes
followed bv dissecting the high and low- molecular weight
DNA containing gel sections (HMW DNA and LMW DNA
respectively as exemplified in Figure 1). Approximately 50006
(X v) sodium hypochlorite solution wxas added to the gel
sections in 20 ml glass vials (Packard. Groningen. The
Netherlands) and the agarose was allowed to dissolve at
70-C. The samples containing HMW DNA were subse-
quently mixed with 5 ml of Hisafe. the samples containing
LMW DNA were mixed with 15 ml of Hisafe scintillation
fluid and counted in a scintillation counter. Samples were
counted for 1 min and disintegrations per second (d.p.s.) were
used in the following formulas to quantify the percentage
DNA fragmentation.
Quantification of the percentage DN-A fragmentation in
the cell pellet:
LXSS D-NA exp. - LNADA DNA-.p?nT X
HMN\V DNA - LM%XV DN A exp.- L\f\V DNA .mrn
Quantification of the total percentaze DNA fragmentation
(cell pellet plus released DNA):
sup. - LMX DUNA pell. exp. - sup.- LAX\ DNA pell. Ispunt.
sup. - HNI\V DN A pell. - LM\\ D- A pell. exp. - sup. - LN\V DNA pell. .pont.
x Ito-Y
In the above formulas: sup. = the amount of d.p.s. assessed in
the supernatant and pell. =the amount of d.p.s. assessed in
the cell pellet. The spontaneous DNA fragmentation and
DNA release w-as determined from a sample to which
medium was added instead of effector cells.
'Cr-release assay
''Cr-release assas-s v-ere performed accordinz to standard
procedures to asses BIS-l-redirected T-cell cvtotoxicitv. All
determinations were done in triplicate in the presence of 60
IU ml-' IL-2. Before the assav. 5 x 10* target cells (GLC-
1Ml3 or GLC-1) w-ere suspended in 100 Ml culture medium
containinz 3.7 MBq Naf'CrO4 (Amersham) and incubated
for I h at 37-C in a humidified. 0o carbon dioxide-
containing atmosphere. Unbound Na,'CrO4 was removed
bv w-ashing the cells three times with medium. Aliquots of
100 p1 of medium containing 2.5 x 10 ;'Cr-labelled target
cells were pipetted into each well of a 96-well round-bottom
microtitre plate. Subsequently. 50 p1 of medium containing
various amounts of BIS-1 and 50 p1 CTL effector cells was
added to each well to give the desired final BIS-1
concentration and effector to target ratio in a final volume
of 200 pl per well. The microtitre plates were centrifuged at
500 r.p.m. for 2 min and incubated at 37-C. 500 carbon
dioxide for the indicated times. After the incubation. the
plates were centrifuged at 1000 r.p.m. for 5 min and 100 Ml
samples taken from the supernatant were counted in an
LKBG gamma counter (LKB Pharmacia) for 5 min. Cell lI-sis
was calculated from the percentage '1Cr released. according
to the formula:
Experimental release-spontaneou. relea.1.u
lMaximal release-spontaneous release
Maximal release was determined from a sample to which
100 p1 of 2°/o Triton X-100 solution was added instead of
BIS-1 and effector cells. Spontaneous release was determined
from a sample to which 50 p1 of medium was added instead
of effector cells.
Resuts
Target cell D.-A fragmentation after BsA4fb-redirected T-cell
c!totoxicitv
EGP-2-positive target cells show-ed apoptosis as a result of
BsMAb-redirected CTL-mediated cytotoxicity. In Figure 1
DNA laddering w-ith DNA fragments of 200 basepair
multimers. characteristic of apoptosis. is visualised after
specific. BIS-1-directed cytotoxicity against the target cell
lines GLC-1M13 (EGP-2-positive) whereas no such laddering
could be established in GLC-1 (EGP-2-negative) cells. in the
CTL population alone. or in the absence of BIS-1.
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Figure 2 Kinetics of target cell death assessed by 'Cr release
(0) DNA fragmentation inside the target cells (A) and total
target cell DNA fraCnentation (v). Cytolytic activit as
assessed after 3 h at vanrous E T ratios in the presence of the
BsMAb BIS-1 against EGP-2-positive GLC-lM13 target cells (a)
and EGP-2-negative GLC-1 target cells (b). Mean values + s.e.
are shown.-_
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Quantification of 3H-thymidine-prelabelled DNA fragmenta-
tion was done by segmentation of the gel into individual
lanes and separation of HMW DNA from LMW DNA-
containing parts of the lane followed by scintillation
counting. By also counting the amount of DNA (frag-
ments) released into the supernatant during the assay, DNA
degradation could be differentiated into DNA fragmentation
inside in as yet intact target cells and the total percentage of
DNA fragmentation. The CTLs, used as the effector cell
population in the experiments shown below, were generated
from PBMCs by an activation protocol described to yield a
cytolytic effector cell population composed of predominantly
CD8-positive T lymphocytes (Weber et al., 1985; Phillips and
Lanier, 1986). Figures 2, 3 and 4 show the percentage DNA
fragmentation in GLC-lM13 and GLC-1 target cells as a
result of BIS-1-redirected CTL activity. DNA fragmentation
was always compared with the results of a simultaneously
performed 51Cr-release assay. The percentage target cell DNA
fragmentation proved to be dependent on the E/T ratio used
(Figure 2), the amount of BIS-1 added to the assay (Figure 3)
and the incubation time (Figure 4). Specific DNA fragmenta-
tion was found in the EGP-2-positive GLC-lM13 target cells
(Figure 2a) but not the EGP-2-negative GLC-1 target cell
(Figure 2b), which is in agreement with the qualitative data
shown in Figure 1. Fragmented DNA was found not only
within the target cells but also in the supernatant, resulting in
an increased total DNA fragmentation compared with the
DNA fragmentation assessable within the target cells. Higher
E/T ratios resulted in an increased fragmentation of target
cell DNA, although chromium-51 release from the target cells
appeared to increase to an even larger extent. Elevated target
cell killing, as reflected by DNA fragmentation, was observed
also as a result of increasing the concentration of BIS-1 in the
cytotoxicity assay (Figure 3). It has been reported that DNA
fragmentation precedes the release of chromium-51 from the
target cells (Duke et al., 1983). Using BIS-1-redirected CTLs,
the time kinetics of DNA fragmentation proved to be
essentially the same as those found with the 5"Cr-release
assay (Figure 4). Using a low E/T ratio (E/T= 1), the
a)
0
= a1)
percentage DNA fragmentation equalled the percentage 5'Cr-
release at each of the assessed time points up to 180 min
(Figure 4b). However, using a high E/T ratio (E/T=20), the
percentage 5"Cr-release increased more rapidly in time than
the percentage DNA fragmentation. Furthermore, in contrast
a
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Figure 3 Cytolytic activity of activated, BIS-l-redirected, CTLs
against GLC-1M13 cells. lCr release (-), DNA fragmentation
inside the target cells (A) and total target cell DNA
fragmentation (V) were assessed at various concentrations of
BIS-1 after 3 h at an E/T ratio of 20. Mean values + s.e. are
shown.
Time (min)
Figure 4 Kinetics of target cell death assessed by 51Cr release
(-), DNA fragmentation inside the target cells (A) and total
target cell DNA fragmentation (V). Cytolytic activity was assessed
after various incubation times at a fixed E/T ratio of 20 in the
presence of the BsMAb BIS-1 against EGP-2-positive GLC-lM13
target cells (a) and EGP-2-negative GLC-1 target cells (b). Mean
values + s.e. values are shown.to cytotoxicity performed at a loxw E T ratio and in parallel
'A-ith the elexated release of chromium-5 1. at a high E T ratio.
substantial DNA release into the supernatant was found.
Confinemzent of DN.4 fragmenration to the relevant target
population
DNA fragmentation can be detected in EGP-'-positive targzet
cells upon specific BIS-1 BsMAb-mediated CTL cytotoxicitv
(Figures 1 -4). In parallel with this induction of apoptosis in
relevant target cells. DNA fragnentation may also become
induced in the CTL population and in innocent. i.e. EGP-'-
negatixve. bystander target cells as a concomitant result of the
specific BsMAb-mediated cytotoxicity. To study this. BIS-1-
directed [ H]thyimidine-prelabelled CTLs wxere used as effector
cells in a cvtotoxicitv assay against unlabelled GLC-1 3
target cells. To assess the amount of DNA fraprmentation in
innocent. i.e. EGP-2-negative. non-effector bxstander cells.
[ H]thvmidine-labelled GLC-1 cells were added to a cyto-
toxicity assax in which specific BIS-1-directed cytotoxicitV
against unlabelled GLC-1M13 u-as induced. The results are
shown in Table I. No DNA fragmentation was found in the
CTL effector cell population nor in the innocent GLC-1
bxstander cells. Of special interest is the fact that transfection
of GLC-1 cells with EGP-2 encoding cDNA (GLC-I.EGP-2)
renders this cell line sensitive to BIS-1-directed lx-sis bv CTLs
as indicated bv both the induction of DNA fragmentation
(Table I) and 'Cr-release (data not shox-n).
Inhibition of DV_.4 fragmnewtatiotn
To further examine whether BIS-1-mediated CTL-induced
target cell DNA fragmentation on the one hand and tarzet
cell l sis as measured bv l'Cr-release on the other. are
independent processes or not. wve assessed the effect of
addition of two known inhibitors of DNA fragmentation. As
shown in Figure 5. the addition of 50 mm zinc chloride or 90
mNi 3.4-dichloroisocoumarin (DCIC) during BIS-1-directed
cellular cvtotoxicitv affected not onlv DNA fragmentation in.
but also the release of chromium-S1 from target cells to the
same extent. These concentrations of zinc chloride or DCIC
did not affect intrinsic lymphocyte functions as assessed in a
lymphocyte proliferation assay using anti-CD3 (MAb WT32)
as mitogenic stimulants (not shown). Threefold higher
concentrations of zinc chloride and DCIC. not onlv further
reduced DNNA fragmentation but also proved to be toxic as a
decreased lymphocyte proliferation capacit xx as noted.
Induction of apoptosis by BsMAb-targeted CTL
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and in performn-independent killinz of tarzet cells by specific
CTLs and natural killer (N-K) cells (Duke et al.. 1983: Hayes
et al.. 1989: Berke. 1991: Heusel et al.. 1994). Apoptosis is
morphologicallx characterised by nuclear condensation.
dissolution of cvtoskeleton intenritv. membrane blebbing
and cellular fra'mentation. These cellular fragments are
called apoptotic bodies and contain condensated nuclear
remnants that show a characteristic pattern of fragmented
DNA multimers of 200 bp upon gel electrophoresis. In this
report we show- that tumour cell DNA fragmentation.
induced bv BsMAb-redirected CTLs. can be demonstrated.
The assav used enables the quantification of LMW and
HMW DNA after agarose zel electrophoresis and allows the
quantification of DNA fragmentation in H-thvmidine-
prelabelled cells. DNA fragmentation is induced in target
cells upon specific BsMAb-mediated recognition by activated
CTLs. In contrast. neither irrelevant target cells nor the
effector cells undergo DNA fragzmentation in the process of
BsMAb-mediated cxytotoxicitv.
These findings suggests that the induction of target cell
DNA fragmentation results from specific cell contact between
the activated CTLs and the target cell rather than from a
generally excreted CTL product. This is further supported by
50 -
40 -
- 30-
.0
-0
20-
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Discussion
e inxestizated the role of apoptosis in BsMAb-directed
cellular cytotoxicity. The phenomenon of apoptosis >xas first
described in 1972 (Kerr et al.. 1972) and is thought to play a
crucial role in the natural manazement of morphogenesis as a
result of cell proliferation, differentiation and death.
Modulation of apoptosis has been implicated in such dixerse
processes as the establishment of an effectixe immune cell
population. the development of leukaemic neoplasia
(Williams. 1991: Fesus et al.. 1991: WAilliams et al.. 1990)
0-
Zn DCIC
Figure 5 Inhibition of BIS-l-redirected CTL-induced target cell
death by the protease inhibitor 3.4-dichloroisocoumarin (DCIC)
and the endonuclease inhibitor Zn- . Target cell death A-as
assessed in the absence or presence of 90 mxi DCIC and 50 m-t
zinc chlonrde bv ;'Cr release (0) from and DNA fragmentation
(=) in ECP-2-positive GLC-1M13 target cells. Cell death Awas
assessed in the presence of BIS-1 after 3 h using an E T ratio of
20.
Table I DN--A fragmentation resulting from BsMlAb-mediated cellular cvtotoxicitV
DN-A fragmentation
Etfector cells Trarget cells assessed in DNA. fragmentation °O
CTL GLC-MIII GLC-IM1I '0
CTL GLC-1 GLC-1
CTL GLC-I.EGP-' GLC1.EGP-' 46
CTL GLC-IMI3 GLC-1
- GLC-I
CTL GLC-IMI3 CTL 0
a DN-.A frainentation was assessed after incubation for 3 h at an E T ratio of20.
Ia duconioft by 1 --gal CTL
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experiments in which no DNA fragmentation was detectable
in irrelevant GLC-1 target cells co-incubated with BIS-1-
directed CTL in the presence of relevant GLC-lM13 target
cells (Table I). Furthermore, no DNA fragmentation could
be induced in either GLC-1 or GLC-IM13 cells by
supernatant harvested from an effective cytolytic experiment
(data not shown). In contrast, GLC-1.EGP-2 cells, GLC-l
cells transfected with the EGP-2 encoding the GA733-2 gene,
are highly susceptible to the cytolytic activity of BIS-1-
directed CTLs and show extensive DNA fragmentation.
Apparently, the resistance of GLC-1 target cells to CTL-
induced DNA fragmentation is not the result of an intrinsic
target cell factor but results purely from the lack of
expression of the relevant target antigen that renders the
cell susceptible to BIS-1 recognition. Apart from the cell lines
shown here, BsMAb-mediated tumour cell DNA fragmenta-
tion could be similarly induced in a large number of other
EGP-2-positive target cell lines (data not shown). This
suggests that the induction of target cell DNA fragmentation
is a common characteristic of BsMAb-mediated target killing
by CTLs. Our data show a correlation between the extent of
the target cell DNA fragmentation and parameters such as
E/T ratio, incubation time and the concentration of BsMAb
used. It has been reported that target cell DNA fragmenta-
tion precedes the release ofchromium-51 from the target cells
(Duke et al., 1983). Our data suggest that in the process of
BsMAb-mediated cytotoxicity, these phenomena have similar
rather than divergent kinetics. This might be a characteristic
of BsMAb-induced cytotoxicity as similar kinetics as
described here have been reported by Curnow et al. (1993)
in the process ADCC. However, in contrast to our results
they showed that, using NK effector cells, an increased E/T
ratio or antibody concentration correlated with increased 51Cr
release from target cells while reducing the amount of
fragmented DNA. It has been postulated that the intrinsic
serine protease activity of granzymes enable these to activate
endogenous target cell endonucleases that are responsible for
the target cell DNA fragmentation (Smyth et al., 1994; Hudig
et al., 1993). Specific serine protease inhibitors such as DCIC
as well as zinc have been described to inhibit endonuclease
activity (Powers et al., 1989; Duke et al., 1983; Shi et al..
1992). We found that not only DNA fragmentation was
effectively suppressed, but also the release of chromium-51
from the target cells was reduced significantly when DCIC or
Zn> was added to the cytotoxicity assay. Apparently the two
entities of target cell destruction cannot be functionally
dissociated here. Isolated perforin has shown to be cytolytic
for target cells without inducing DNA fragmentation (Duke
et al., 1989). However in a more physiological setting it was
shown that non-cytolytic rat basophilic leukaemia (RBL)
cells could be turned into cytotoxic active effector cells only
by co-transfection with both the perforin and granzyme A
genes (Shiver et al., 1992). This suggests that these different
cytolytic components do not act separately but are needed
together to induced effective cell destruction. In this concept,
perforin might be involved in destabilisation of the target cell
membrane, allowing granzymes to enter the target cell and to
encounter their intracellular substrates. Deregulation of the
target cell function by granzymes and possibly other cytolytic
components in turn prevents effective membrane repair
mechanisms resulting in the disturbed cellular homeostasis
as measured with 5"Cr-release from the target cell (Heusel et
al.. 1994). This is in line with observations reported by Shi et
al. (1992) who showed that DNA fragmentation in target
cells was dependent on prior treatment of these target cells
with sublethal concentrations of perforn.
Besides perforn, other mechanisms have been shown to be
involved in the lethal hit delivery of CTLs. An important
recently described effector mechanism seems to be mediated
through the target cell-expressed Fas receptor, which has a
widespread cellular distribution (Nagata and Golstein, 1995).
Interaction of the Fas receptor with the Fas ligand, which is
up-regulated on activated CTLs, initiates an apoptotic
program within the target cell that does not require
extracellular Ca2 or de novo protein synthesis. Fas-mediated
target cell killing has been implicated in the non-antigen-
specific killing of CTLs (Rouvier et al., 1993; Lowin et al.,
1994) and is characterised by the induction of an apoptotic
suicide programme in the target cell. It seems unlikely
however, that Fas-mediated killing played a significant role
in the results described in this report since the non-specific
(innocent bystander) killing was not observed in our
experiments whereas GLC-1 as well as GLC-1M13 are both
Fas positive (data not shown). Furthermore, no inter-effector
cell killing was observed (Table I) while these were found to
be both Fas as well as Fas-ligand positive (data not shown).
An implication ofthe results shown in the present report is
that clinical evaluation of the in vivo effectiveness of BsMAb-
mediated T-cell targeting might be possible. BsMAb-
mediated cellular immunotherapy has evolved over the last
few years and clinical application is currently being
investigated (Kroesen et al., 1994). The need for evaluation
of functional in vivo targeting has become apparent and
protocols that have been described to specifically detect
apoptotic cells either by flow cytometry or immunological
staining biopsies (Wijsman et al., 1993; Gorczyca et al., 1993)
might be helpful in this respect.
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